All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The SOT Hub is an independent medical education platform, supported through a founding grant from Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View solid organ transplantation content recommended for you
Conjugated antibodies
Conjugated antibodies are targeted biologic therapies in which an antibody is linked to a therapeutic payload, which may include an immunomodulatory, cytotoxic, anti-inflammatory, or other bioactive agent. In solid organ transplantation, these approaches are being explored to target cells or pathways involved in alloimmune activation, graft injury, or rejection, with the aim of enhancing localized immunomodulation while limiting broader off-target effects.
Filter by content: